Profile cover photo
Profile photo
m semporda
Stem Cell Sector Analyst / SciComms - @msemporda
Stem Cell Sector Analyst / SciComms - @msemporda
About
Posts

Post has attachment
**
Japan Announces Physician-initiated clinical trials for Parkinson's disease using iPSCs Kyoto University Hospital, in partnership with the Center for iPS Cell Research and Application (CiRA), Kyoto University, has planned physician-initiated clinical trials...
Add a comment...

Post has attachment
Early Safety and Efficacy Data in Cynata’s Phase 1 Trial of CYP-001 in GvHD
Encouraging Early Safety and Efficacy Data in Cynata’s Phase
1 Trial of CYP-001 in GvHD; DSMB Recommendation to Initiate Enrolment
of Second Patient Cohort Australian stem cell and regenerative medicine company, Cynata
Therapeutics Limited (ASX: CYP) is ple...
Add a comment...

Post has attachment
Parthenotes - Flying Under the Radar of Pluripotent Science
Positive interim results in the 1st in human study of parthenogenetically derived neural stem cells ("hpNSCs") for Parkinson's Disease were recently announced by International Stem Cell Corp. ("ISCO"). From the announcement the cells have to-date been well ...
Add a comment...

Post has attachment
Methods & Mechanics, Protocols & Parameters...

Cell science is poised to deliver on its promise and open up new modalities in the war against disease with the rubik of product characterization playing a central role.

Article: "Cynata & The Rubik of Cell Science" - http://msemporda.blogspot.com/2017/01/cynata-rubik-of-cell-science.html

Cheers

Post has attachment
Cynata & The Rubik of Cell Science
As with the sun rising in the East so have the first two pioneering programs using Induced Pluripotent Stem Cell (iPSC) technology for human clinical study. Independently initiated, but now strategic brethren, the Japanese and Australian efforts to provide ...
Add a comment...

Post has shared content
A pharmacology lab developed a process that directs light waves at circulating blood cells to release drugs stored in those cells at precise times and locations. #Science #Business #Technology #Health
Add a comment...

Post has attachment
"The N Factor"

The mere mention of a possible stop-gap option to the grave medical realities of those that suffer, let alone a lifeline to a solution, is enough to get most patients and their families/friends talking. Clinical trials however are relatively few and far between...

http://msemporda.blogspot.com/2017/01/the-n-factor_3.html
Add a comment...

Post has shared content
A combination of dental pulp stem cells and cells from human umbilical cords, mixed with a common hydrogel, were shown in lab rats to regenerate pulp-like tissue in teeth roots. #Science #Technology #Health
Add a comment...

Post has shared content
Light therapy to treat early prostate cancer.

The technique, in which a light-sensitive chemical is activated by a laser when it reaches cancer cells, could spare many patients the trauma of surgery or radiotherapy.

http://bit.ly/2hTwkDq, http://bbc.in/2i9fxuS
Photo
Add a comment...

Post has shared content
A pharmaceutical company and health care venture investor are forming BlueRock Therapeutics, a biotechnology enterprise to design regenerative medicine treatments with stem cells. #Science #Business #Technology #Health
Add a comment...
Wait while more posts are being loaded